Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Drug interactions & pharmacokinetics

13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona

Editor's pick
i-base
23 May 2012
New & experimental HIV treatments

Broad-Spectrum Antivirals: The Future of HIV Treatment?

Editor's pick
The Body
17 May 2012
New & experimental HIV treatments

FDA Panel Endorses 'Quad' Pill for HIV

Editor's pick
MedPage Today HIV/AIDS
14 May 2012
New & experimental HIV treatments

Gilead’s Quad Pill Raises Kidney Questions, FDA Says

Editor's pick
Bloomberg Business Week
9 May 2012
The search for a cure

Study using stem cell therapy shows promise in fight against HIV

Editor's pick
Eurekalert Inf Dis
3 May 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
Government, leadership & policy

Three Big HIV Days in May at the FDA

Editor's pick
AIDSMeds
19 April 2012
New & experimental HIV treatments

DFH Pharma to Collaborate with National Institutes of Health to Develop 2nd Generation HIV Maturation Inhibitor Drugs

Editor's pick
PR Newswire
16 April 2012
Side effects

CROI: Crofelemer Reduces Diarrhea in People with HIV; FDA Grants Priority Review

Editor's pick
HIVandHepatitis.com
13 April 2012
The search for a cure

Engineering CD8 Cells to Kill HIV in Tissues

Editor's pick
AIDSMeds
13 April 2012
Pharmaceutical industry

Gilead And The Future of HIV Therapy

Editor's pick
The Street
10 April 2012
New & experimental HIV treatments

GSK's new once-daily HIV drug matches Merck rival

Editor's pick
Reuters
2 April 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study

Editor's pick
ViiV Healthcare (press release)
2 April 2012
HIV treatment for children & young people

FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1

Editor's pick
Janssen press release
28 March 2012
New & experimental HIV treatments

Avexa closer to EMA approval for ATC

Editor's pick
Australian Life Scientist
23 March 2012
New & experimental HIV treatments

Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?

Editor's pick
AIDSMeds.com
21 March 2012
Cardiovascular disease

CROI 2012 Really Rapid Review, by Dr Paul Sax

Editor's pick
The Body
21 March 2012
The search for a cure

Zolinza May Help Reduce Latent HIV Reservoirs In People With HIV (CROI 2012)

Editor's pick
The AIDS Beacon
10 March 2012
New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
The search for a cure

Drug brings HIV out of hiding

Editor's pick
Nature
9 March 2012
TB treatment

High dose of new HIV drug might improve outcomes for HIV/TB co-infected

Editor's pick
Science Speaks
8 March 2012
New & experimental HIV treatments

Gilead's Quad Single Tablet Regimen For HIV Non-Inferior To Atripla In Study

Editor's pick
NASDAQ
7 March 2012
New & experimental HIV treatments

ViiV's Dolutegravir Continues to Show Well After 96 Weeks, Versus Sustiva, for First-Time Treatment

Editor's pick
AIDSMeds
7 March 2012